145 related articles for article (PubMed ID: 23355550)
1. Authors' response: Metformin and risk of hepatocellular carcinoma--a study focused on anti-diabetic agents.
Wu CY; Chen HP
Gut; 2013 Jun; 62(6):952. PubMed ID: 23355550
[No Abstract] [Full Text] [Related]
2. Metformin and risk of hepatocellular carcinoma: are statins the missing link?
Singh S; Singh PP
Gut; 2013 Jun; 62(6):951-2. PubMed ID: 23263525
[No Abstract] [Full Text] [Related]
3. Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome.
Cauchy F; Mebarki M; Albuquerque M; Laouirem S; Rautou PE; Soubrane O; Raymond E; Bedossa P; Paradis V
Gut; 2015 Sep; 64(9):1498-500. PubMed ID: 26123027
[No Abstract] [Full Text] [Related]
4. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.
Chen HP; Shieh JJ; Chang CC; Chen TT; Lin JT; Wu MS; Lin JH; Wu CY
Gut; 2013 Apr; 62(4):606-15. PubMed ID: 22773548
[TBL] [Abstract][Full Text] [Related]
5. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus and metformin in hepatocellular carcinoma.
Fujita K; Iwama H; Miyoshi H; Tani J; Oura K; Tadokoro T; Sakamoto T; Nomura T; Morishita A; Yoneyama H; Masaki T
World J Gastroenterol; 2016 Jul; 22(27):6100-13. PubMed ID: 27468203
[TBL] [Abstract][Full Text] [Related]
7. Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus.
Donadon V; Balbi M; Zanette G
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):465-7. PubMed ID: 19817667
[No Abstract] [Full Text] [Related]
8. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
Cunha V; Cotrim HP; Rocha R; Carvalho K; Lins-Kusterer L
Ann Hepatol; 2020; 19(3):232-237. PubMed ID: 31836424
[TBL] [Abstract][Full Text] [Related]
9. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.
Zhang ZJ; Zheng ZJ; Shi R; Su Q; Jiang Q; Kip KE
J Clin Endocrinol Metab; 2012 Jul; 97(7):2347-53. PubMed ID: 22523334
[TBL] [Abstract][Full Text] [Related]
10. Diabetes medications and risk of HCC.
Plaz Torres MC; Jaffe A; Perry R; Marabotto E; Strazzabosco M; Giannini EG
Hepatology; 2022 Dec; 76(6):1880-1897. PubMed ID: 35239194
[TBL] [Abstract][Full Text] [Related]
11. Recent Insights of Metformin on Hepatocellular Carcinoma (HCC).
Wang K; Zhang K; Zhang X; Chen D; Jiang S
Mini Rev Med Chem; 2023; 23(11):1154-1166. PubMed ID: 35747976
[TBL] [Abstract][Full Text] [Related]
12. Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection.
Chan KM; Kuo CF; Hsu JT; Chiou MJ; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Lee WC
Liver Int; 2017 Mar; 37(3):434-441. PubMed ID: 27775209
[TBL] [Abstract][Full Text] [Related]
13. Role of metformin in the diagnosis, prevention, and treatment of hepatocellular carcinoma.
Xiong S; Liu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):364-373. PubMed ID: 35545330
[TBL] [Abstract][Full Text] [Related]
14. Metformin therapy and its anti-neoplastic role in systemic malignancies besides hepatocellular carcinomas.
Kapoor S
Scand J Gastroenterol; 2013 May; 48(5):636-7. PubMed ID: 23477305
[No Abstract] [Full Text] [Related]
15. [The risk is higher, but why?].
Stiefelhagen P
MMW Fortschr Med; 2016 Mar; 158(6):18. PubMed ID: 27084135
[No Abstract] [Full Text] [Related]
16. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease.
Donadon V; Balbi M; Ghersetti M; Grazioli S; Perciaccante A; Della Valentina G; Gardenal R; Dal Mas M; Casarin P; Zanette G; Miranda C
World J Gastroenterol; 2009 May; 15(20):2506-11. PubMed ID: 19469001
[TBL] [Abstract][Full Text] [Related]
17. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.
Tajima K; Nakamura A; Shirakawa J; Togashi Y; Orime K; Sato K; Inoue H; Kaji M; Sakamoto E; Ito Y; Aoki K; Nagashima Y; Atsumi T; Terauchi Y
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E987-98. PubMed ID: 23964070
[TBL] [Abstract][Full Text] [Related]
18. Mysterious metformin.
Chong CR; Chabner BA
Oncologist; 2009 Dec; 14(12):1178-81. PubMed ID: 20007645
[No Abstract] [Full Text] [Related]
19. Coffee and the risk of hepatocellular carcinoma: misleading analysis of the data.
Huang XY; Hu C
Eur J Cancer Prev; 2018 Jul; 27(4):315. PubMed ID: 29688907
[No Abstract] [Full Text] [Related]
20. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation.
Chen TM; Lin CC; Huang PT; Wen CF
J Gastroenterol Hepatol; 2011 May; 26(5):858-65. PubMed ID: 21251068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
